The iShares S&P Mid-Cap 400 Value ETF (IJJ) has an implied analyst target price of $140.30 per unit, indicating a potential upside of 14.96% from its current trading price of $122.04. This valuation is based on the weighted average of target prices for its underlying holdings.
Notable underlying stocks with significant upside potential include Haemonetics Corp. (HAE), with a target price of $92.30 (25.75% upside from $73.40); Jones Lang LaSalle Inc (JLL), with a target of $302.75 (23.82% upside from $244.50); and MKS Inc. (MKSI), with a target of $116.67 (18.25% upside from $98.66).
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| iShares S&P Mid-Cap 400 Value ETF | IJJ | $122.04 | $140.30 | 14.96% |
| Haemonetics Corp. | HAE | $73.40 | $92.30 | 25.75% |
| Jones Lang LaSalle Inc | JLL | $244.50 | $302.75 | 23.82% |
| MKS Inc. | MKSI | $98.66 | $116.67 | 18.25% |
